Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system

Eitemau Tebyg

• Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure
  gan: Prébet, Thomas, et al.
  Cyhoeddwyd: (2012)
• Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
  gan: Prébet, Thomas, et al.
  Cyhoeddwyd: (2011)
• Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure
  gan: Prébet, Thomas, et al.
  Cyhoeddwyd: (2013)
• The role of azacitidine in the management of myelodysplastic syndromes (MDS)
  gan: Götze, KS, et al.
  Cyhoeddwyd: (2009)
• MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine
  gan: Breccia, Massimo, et al.
  Cyhoeddwyd: (2012)